Exclusive: Nvidia Snaps Kumo in Major AI Acquisition
Nvidia has acquired Kumo AI, adding enterprise-focused foundation models to its AI stack. Founders join Nvidia, with ...
Which Fund Family Has Best Sharpe Ratio Indices
Learn which fund family offers the best Sharpe ratio indices and why it matters for risk-adjusted performance. Compare funds to identify strong performers.
28,055 articles
Cramer Says Skip Klarna Amid Ongoing BNPL Buzz Turbulence
Jim Cramer signals a clear pecking order in payments, naming Klarna as the one to avoid while highlighting Affirm and...
Bitcoin Price Trading $66,000 Gap Deepens as Liquidity Dries
Bitcoin has fallen out of step with broad money growth, creating a large gap between its price and M2-derived fair va...
Inside Jane Fraser’s 5-Year Turnaround at Citi Unfolds
Five years into Citi CEO Jane Fraser’s tenure, a sweeping rebuild has shifted the bank from risk and tech bottlenecks...
Why Zebra Technologies Stock Jumped: Key Drivers Today
Zebra Technologies stock jumped sharply this morning after a solid Q1 2026 report. This article breaks down the numbe...
Trump Adds Coinbase and Bitcoin Stocks to Portfolio
A May 14, 2026 filing shows Trump boosting crypto exposure by buying Coinbase and Bitcoin-related stocks, a notable m...
Openlane Stock Drawing Institutional Interest: What Investors See
As institutional buyers step into Openlane, individual investors gain a front-row seat to a digitized used-vehicle ma...
Missed First Wave? These Stocks Are Still Genius Picks
The AI boom isn’t over. If you felt you missed the first wave, these three resilient stocks deliver real AI leverage,...
Unstoppable Stock Before Rejoins: Microsoft Eyes $4T Club
One mega-cap could re-enter the elite $4 trillion club, powered by AI, cloud momentum, and strong cash flow. This pie...
Texas Instruments Smashing NVIDIA in 2026: Market Shakeup
Texas Instruments is outperforming NVIDIA in 2026 as the chip landscape shifts from GPU hype to broad AI infrastructu...
UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status